KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Accured Expenses (2016 - 2025)

Rigel Pharmaceuticals has reported Change in Accured Expenses over the past 16 years, most recently at $1.8 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 16.52% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 21.33%, while the annual FY2025 figure was $1.8 million, 21.33% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $1.8 million at Rigel Pharmaceuticals, down from $2.2 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $5.9 million in Q2 2022 and troughed at -$4.1 million in Q1 2025.
  • A 5-year average of -$40900.0 and a median of $104000.0 in 2021 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: soared 408.13% in 2022 and later crashed 4174.26% in 2025.
  • Year by year, Change in Accured Expenses stood at $107000.0 in 2021, then crashed by 3334.58% to -$3.5 million in 2022, then skyrocketed by 58.54% to -$1.4 million in 2023, then skyrocketed by 254.36% to $2.2 million in 2024, then fell by 16.52% to $1.8 million in 2025.
  • Business Quant data shows Change in Accured Expenses for RIGL at $1.8 million in Q4 2025, $2.2 million in Q3 2025, and $1.9 million in Q2 2025.